Voice News BD

New drug combo shrinks tumors in most patients facing aggressive cancer type

The pancreatic cancer pill daraxonrasib shrank tumors in 60.7% of patients when paired with chemotherapy, and 8.2% saw tumors vanish on scans.

Covered by 1 source ·

New drug combo shrinks tumors in most patients facing aggressive cancer type
Share

Every side

  • Fox News
    mixed factuality Fox Corporation (Murdoch family) · corporate

    The pancreatic cancer pill daraxonrasib shrank tumors in 60.7% of patients when paired with chemotherapy, and 8.2% saw tumors vanish on scans.

    Read original →

← All stories on Voice News BD